Drug intelligence / Profile preview

fangxia dihuang tang

Development stage: Unknown
Lead developer: Xiamen Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Fangxia Dihuang Tang is a Traditional Chinese Medicine (TCM) herbal formula being investigated by the Xiamen Hospital of Traditional Chinese Medicine. It is primarily studied for its potential therapeutic effects in treating chemotherapy-related anxiety disorder in patients with breast cancer. The formula's mechanism of action is hypothesized to involve the gut-brain axis, with research focusing on its ability to modulate intestinal microbiota, influence intestinal metabolites, and alter gene expression (mRNA) in the blood. Additionally, clinical studies utilize neuroimaging to observe changes in specific brain regions associated with anxiety following treatment with this decoction.

Brand names: Fangxia Dihuang Tang
Other names: Fangxia Dihuang Tang

Beyond the preview

Go deeper on fangxia dihuang tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fangxia dihuang tang.

Explore the full profile